BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2026 3:41:46 AM | Browse: 1 | Download: 1
 |
Received |
|
2025-11-28 00:48 |
|
Peer-Review Started |
|
2025-11-28 00:48 |
|
First Decision by Editorial Office Director |
|
2025-12-11 09:40 |
|
Return for Revision |
|
2025-12-11 09:40 |
|
Revised |
|
2025-12-17 06:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-26 02:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-26 10:31 |
|
Articles in Press |
|
2026-01-26 10:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-04 01:12 |
|
Publish the Manuscript Online |
|
2026-02-11 03:41 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jyoti Pathania and Vanya Pathania |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jyoti Pathania, Department of Anesthesia, Rohilkhand Medical College, Pilbhit bypass road, Bareilly 243006, Uttar Pradesh, India. pathaniajyoti7@gmail.com |
| Key Words |
Short bowel syndrome; Parenteral nutrition; Teduglutide; Diarrhea; Malabsorption syndromes |
| Core Tip |
Teduglutide (rDNA) is a Food and Drug Administration sanctioned medication for individuals with short bowel syndrome. The majority of short bowel syndrome patients receive parenteral support, and this medication enhances their chances of achieving parenteral independence to different extents. Daily subcutaneous injections are routinely prescribed, along with regular gastrointestinal colonoscopies/endoscopies to observe the enterocyte dysplasia present in certain individuals. The expensive nature of the treatment significantly discourages its regular use, leading the prescribing physician to adjust its dosage. Nonetheless, only a limited number of treatment-related side effects are seen, making it the sole pharmacological choice for these patients. |
| Publish Date |
2026-02-11 03:41 |
| Citation |
Pathania J, Pathania V. Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome. World J Gastrointest Pharmacol Ther 2026; 17(1): 117071 |
| URL |
https://www.wjgnet.com/2150-5349/full/v17/i1/117071.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v17.i1.117071 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
